Literature DB >> 17016720

Eccrine ductal and acrosyringeal differentiation of the breast epithelium--a lesion associated with some metaplastic breast carcinomas.

Tibor Tot1.   

Abstract

Two cases of metaplastic breast carcinoma associated with eccrine ductal metaplasia in the surrounding breast tissue are reported. The metaplastic epithelium deviated from the normal in its immunophenotype not expressing glandular cytokeratins (Cam 5.2) and estrogen receptors, being maspin-positive, and resembling morphologically different segments of dermal eccrine duct and acrosyringium. In addition, in one of the cases, basalioma-like intraductal cell proliferation was observed, also showing focal acrosyringeal differentiation. The invasive carcinomas, one of them representing "syringomatous squamous tumor of the breast" while the other diagnosed as high-grade metaplastic carcinoma, also showed focal eccrine and acrosyringeal differentiation and intensive diffuse maspin expression. These previously unrecognized metaplastic changes of the breast epithelium may represent precursor lesions of certain types of metaplastic breast carcinomas.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17016720     DOI: 10.1007/s00428-006-0281-7

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  18 in total

1.  Maspin expression in normal skin and usual cutaneous carcinomas.

Authors:  Jorge S Reis-Filho; Beatriz Torio; André Albergaria; Fernando C Schmitt
Journal:  Virchows Arch       Date:  2002-09-25       Impact factor: 4.064

2.  An unusual, recurring breast tumor with features of eccrine spiradenoma: a case report.

Authors:  L Panico; A D'Antonio; R Chiacchio; P Delrio; G Petrella; G Pettinato
Journal:  Am J Clin Pathol       Date:  1996-11       Impact factor: 2.493

3.  KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome.

Authors:  Sandy Azoulay; Marick Laé; Paul Fréneaux; Solange Merle; Abir Al Ghuzlan; Caroline Chnecker; Christophe Rosty; Jerzy Klijanienko; Brigitte Sigal-Zafrani; Rémy Salmon; Alain Fourquet; Xavier Sastre-Garau; Anne Vincent-Salomon
Journal:  Mod Pathol       Date:  2005-12       Impact factor: 7.842

4.  Squamous metaplasia of the breast. An ultrastructural and immunologic evaluation.

Authors:  R L Reddick; J C Jennette; F B Askin
Journal:  Am J Clin Pathol       Date:  1985-10       Impact factor: 2.493

5.  Novel and classic myoepithelial/stem cell markers in metaplastic carcinomas of the breast.

Authors:  Jorge S Reis-Filho; Fernanda Milanezi; Joana Paredes; Paula Silva; Emílio M Pereira; Sueli A Maeda; Leda V de Carvalho; Fernando C Schmitt
Journal:  Appl Immunohistochem Mol Morphol       Date:  2003-03

6.  Syringomatous adenoma of the nipple.

Authors:  P P Rosen
Journal:  Am J Surg Pathol       Date:  1983-12       Impact factor: 6.394

7.  Eccrine differentiation in basal cell carcinoma.

Authors:  P J Heenan; M S Bogle
Journal:  J Invest Dermatol       Date:  1993-03       Impact factor: 8.551

8.  Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer.

Authors:  Bradley B Bryan; Stuart J Schnitt; Laura C Collins
Journal:  Mod Pathol       Date:  2006-05       Impact factor: 7.842

Review 9.  Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium: a new progenitor (adult stem) cell concept.

Authors:  Werner Boecker; Horst Buerger
Journal:  Cell Prolif       Date:  2003-10       Impact factor: 6.831

10.  CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation.

Authors:  C Jones; A V Nonni; L Fulford; S Merrett; R Chaggar; V Eusebi; S R Lakhani
Journal:  Br J Cancer       Date:  2001-08-03       Impact factor: 7.640

View more
  1 in total

1.  Eccrine ductal and acrosyringeal metaplasia in breast carcinomas: report of eight cases.

Authors:  Tibor Tot
Journal:  Virchows Arch       Date:  2018-11-22       Impact factor: 4.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.